SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GARY P GROBBEL who wrote (546)12/5/1999 10:10:00 AM
From: VultureInvest  Read Replies (1) of 670
 
Gary - Totally agree. PRCY is not a penny stock company. The entire dermabrasion market is going gangbuster, and there is limited competition with the healing cremes following treatment.
Yet this is only one of many markets Procyte is addressing. Notice how Procyte has developed products that augment larger dermatology/cosmetic product offerings? Strategy is good, management is strong, products exceptional, no debt, 19 U.S. patents and over 130 internationally, good cash position for several years, sales perhaps to more than double this year, major distribution deals signed and beginning to deliver. Waiting for the Avon girl to ring the doorbell, but hopefully not until we see the $20 range before an offer is on the table. I am also buying while all is quiet on the western front. Maybe it has something to do with Peace demonstration and distractions away from Redmond to Seattle.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext